FDA Approves Alzheimer’s Drug

FDA Approves Alzheimer’s Drug – June 8, 2021

Yesterday, the FDA approved a new Alzheimer’s treatment, which is one of the first breakthroughs in about 20 years. At Azura Memory Care, we see every day first hand  what this disease does to families and their loved ones. 

“Alzheimer’s disease is a progressive neurodegenerative disorder that slowly destroys memory and thinking skills. More than 6 million Americans are living with it, according to estimates by the Alzheimer’s Association. By 2050, that number is projected to rise to nearly 13 million, according to the group.” (Lovelace, 2021.)

Previous to this, there were no drugs cleared by the FDA that were capable of showing the mental decline from Alzheimer’s. The FDA approved the drug for aiding symptoms and making them less prevalent, but hasn’t shown any results of diminishing it, yet. 

“It is a new day,” Harry Johns, CEO of the Alzheimer’s Association, said in a statement. “This approval allows people living with Alzheimer’s more time to live better. For families it means being able to hold on to their loved ones longer. It is about reinvigorating scientists and companies in the fight against this scourge of a disease. It is about hope.” (Lovelace, 2021) 

To read more, click here.






Leave A Comment

Assisted Living & Memory Care Reviews